556 results on '"Schmitz, Joy M."'
Search Results
2. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial
3. Prenatal cocaine exposure and its influence on pediatric epigenetic clocks and epigenetic scores in humans
4. Behavioral therapies targeting reward mechanisms in substance use disorders
5. Trauma and Emotion Regulation: Associations with Depressive Symptoms and Cocaine Use among Treatment-seeking Adults
6. Biomarkers in Substance Use Disorder
7. Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART)
8. An opioid-minimizing multimodal pain regimen reduces opioid exposure and pain in trauma-injured patients at high risk for opioid misuse: Secondary analysis from the mast trial
9. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial
10. Deficits in consummatory reward relate to severity of cocaine use
11. 546 Using Contingency Management to Understand the Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use: A Protocol for a Randomized Controlled Trial
12. Late positive potential as a candidate biomarker of motivational relevance in substance use: Evidence from a meta-analysis
13. Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study
14. Comorbid alcohol use and post-traumatic stress disorders: Pharmacotherapy with aldehyde dehydrogenase 2 inhibitors versus current agents
15. Citalopram for treatment of cocaine use disorder: A Bayesian drop-the-loser randomized clinical trial
16. A meta‐analysis of electrophysiological biomarkers of reward and error monitoring in substance misuse
17. Posttraumatic stress symptom clusters differentially predict late positive potential to cocaine imagery cues in trauma-exposed adults with cocaine use disorder
18. Decreased cocaine demand following contingency management treatment
19. The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis
20. Assessing Stage of Change and Harm Reduction Strategies for Synthetic Cannabinoid Use Among Individuals Experiencing Homelessness in Houston, Texas
21. Opioid Risk Tool, in-hospital opioid exposure, and opioid demand predict pain outcomes following traumatic injury.
22. Mindfulness as a predictor of cognitive-behavioral therapy outcomes in inner-city adults with posttraumatic stress and substance dependence
23. Reducing Tobacco Smoke Exposure in High-Risk Infants: A Randomized, Controlled Trial
24. Mental Health Clinician Practices and Perspectives on Treating Adults with Co-Occurring Posttraumatic Stress and Substance Use Disorders
25. Regional differences in white matter integrity in stimulant use disorders: A meta-analysis of diffusion tensor imaging studies
26. A Novel, Integrated Cognitive-Behavioral Therapy for Co-Occurring Posttraumatic Stress and Substance Use Disorders: A Case Study
27. Cigarette smoking, type 2 diabetes mellitus, and glucagon-like peptide-1 receptor agonists as a potential treatment for smokers with diabetes: An integrative review
28. Using a data science approach to predict cocaine use frequency from depressive symptoms
29. White matter deficits in cocaine use disorder: convergent evidence from in vivo diffusion tensor imaging and ex vivo proteomic analysis
30. Assessing cocaine motivational value: Comparison of brain reactivity bias toward cocaine cues and cocaine demand.
31. Initial development of a brief assessment of cocaine demand
32. Altered anterior cingulate cortex to hippocampus effective connectivity in response to drug cues in men with cocaine use disorder
33. Types of Traumatic Experiences in Drug Overdose-Related Deaths: An Exploratory Latent Class Analysis
34. A preliminary longitudinal study of white matter alteration in cocaine use disorder subjects
35. Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder
36. Pharmacological treatment of psychostimulant use disorders.
37. Assessing Stage of Change and Harm Reduction Strategies for Synthetic Cannabinoid Use Among Individuals Experiencing Homelessness in Houston, Texas
38. Electrophysiological responses to emotional and cocaine cues reveal individual neuroaffective profiles in cocaine users.
39. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa–carbidopa, naltrexone
40. Using prize-based incentives to enhance daily interactive voice response (IVR) compliance: A feasibility study
41. PPAR‐gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double‐blind randomized controlled pilot trial
42. The Role of Homework in Cognitive-Behavioral Therapy for Cocaine Dependence
43. A Stage I pilot study of acceptance and commitment therapy for methadone detoxification
44. Nonjudgmental acceptance: Associations with substance-related cue reactivity in adults with substance use disorders and posttraumatic stress
45. Increased intra-individual reaction time variability in cocaine-dependent subjects: Role of cocaine-related cues
46. Trauma and Emotion Regulation: Associations with Depressive Symptoms and Cocaine Use among Treatment-seeking Adults
47. The potential of brain stimulation techniques for substance use disorder treatment
48. Distress tolerance: prospective associations with cognitive-behavioral therapy outcomes in adults with posttraumatic stress and substance use disorders
49. Behavioral Mechanisms in Addiction
50. Increasing the Information Yield From Clinical Trials in Addictions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.